Literature DB >> 15196248

Polyreactive antigen-binding B (PAB-) cells are widely distributed and the PAB population consists of both B-1+ and B-1- phenotypes.

Z-H Zhou1, A L Notkins.   

Abstract

B cells that make polyreactive antibodies (PAB+ cells) express polyreactive Ig receptors on their surface and can bind a variety of different antigens. The present study shows that PAB+ cells are widely distributed, are present in varying numbers in different lymphoid organs and that their phenotype varies depending on the organs from which they are isolated. Up to 10 times more cells in PAB+ enriched populations bind antigens as compared to PAB- populations. Comparison of PAB+ with B-1+ cells showed that a high percentage of PAB+ cells are B-1+, but that many PAB+ cells do not express B-1 cell surface markers and, in fact, are B-1-. It is concluded that the B cell population consists of PAB+/B-1+, PAB+/B-1-, PAB-/B-1+, and PAB-/B-1- cells. The presence of PAB+ cells in the thymus points to the possibility that PAB+ cells may carry endogenous host antigens from peripheral tissues to the thymus where they may contribute to immunological tolerance.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15196248      PMCID: PMC1809069          DOI: 10.1111/j.1365-2249.2004.02511.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  57 in total

1.  Evidence for selection of a population of multi-reactive B cells into the splenic marginal zone.

Authors:  X Chen; F Martin; K A Forbush; R M Perlmutter; J F Kearney
Journal:  Int Immunol       Date:  1997-01       Impact factor: 4.823

2.  Antigen-binding B cells and polyreactive antibodies.

Authors:  Z J Chen; J Wheeler; A L Notkins
Journal:  Eur J Immunol       Date:  1995-02       Impact factor: 5.532

Review 3.  B-1 cells and their reactivity with the murine intestinal microflora.

Authors:  F G Kroese; R de Waard; N A Bos
Journal:  Semin Immunol       Date:  1996-02       Impact factor: 11.130

4.  Structural insights into the evolution of an antibody combining site.

Authors:  G J Wedemayer; P A Patten; L H Wang; P G Schultz; R C Stevens
Journal:  Science       Date:  1997-06-13       Impact factor: 47.728

5.  Polyreactive antigen-binding B cells in the peripheral circulation are IgD+ and B7-.

Authors:  Z J Chen; F Shimizu; J Wheeler; A L Notkins
Journal:  Eur J Immunol       Date:  1996-12       Impact factor: 5.532

6.  Polyreactive IgM antibodies in the circulation are masked by antigen binding.

Authors:  G Sigounas; N Kolaitis; E Monell-Torrens; A L Notkins
Journal:  J Clin Immunol       Date:  1994-11       Impact factor: 8.317

7.  Analysis of the structural correlates for antibody polyreactivity by multiple reassortments of chimeric human immunoglobulin heavy and light chain V segments.

Authors:  Y Ichiyoshi; P Casali
Journal:  J Exp Med       Date:  1994-09-01       Impact factor: 14.307

8.  Diverse binding site structures revealed in homology models of polyreactive immunoglobulins.

Authors:  P A Ramsland; L W Guddat; A B Edmundson; R L Raison
Journal:  J Comput Aided Mol Des       Date:  1997-09       Impact factor: 3.686

9.  Both VH and VL chains of polyreactive IgM antibody are required for polyreactivity: expression of Fab in Escherichia coli.

Authors:  S C Cheung; S Takeda; A L Notkins
Journal:  Clin Exp Immunol       Date:  1995-08       Impact factor: 4.330

10.  Development of B-1 cells: segregation of phosphatidyl choline-specific B cells to the B-1 population occurs after immunoglobulin gene expression.

Authors:  L W Arnold; C A Pennell; S K McCray; S H Clarke
Journal:  J Exp Med       Date:  1994-05-01       Impact factor: 14.307

View more
  10 in total

Review 1.  Polyreactive antibodies in adaptive immune responses to viruses.

Authors:  Hugo Mouquet; Michel C Nussenzweig
Journal:  Cell Mol Life Sci       Date:  2011-11-02       Impact factor: 9.261

Review 2.  Properties and function of polyreactive antibodies and polyreactive antigen-binding B cells.

Authors:  Zhao-Hua Zhou; Athanasios G Tzioufas; Abner Louis Notkins
Journal:  J Autoimmun       Date:  2007-09-20       Impact factor: 7.094

3.  The broad antibacterial activity of the natural antibody repertoire is due to polyreactive antibodies.

Authors:  Zhao-Hua Zhou; Yahong Zhang; Ya-Fang Hu; Larry M Wahl; John O Cisar; Abner Louis Notkins
Journal:  Cell Host Microbe       Date:  2007-03-15       Impact factor: 21.023

Review 4.  Homeostasis and regulation of autoreactive B cells.

Authors:  Sujin Lee; Yeunjung Ko; Tae Jin Kim
Journal:  Cell Mol Immunol       Date:  2020-05-07       Impact factor: 11.530

5.  Autoantibodies: Focus on anti-DNA antibodies.

Authors:  Nina Almqvist; Thomas H Winkler; Inga-Lill Mårtensson
Journal:  Self Nonself       Date:  2011-01-01

6.  Evidence to Support a Contribution of Polyreactive Antibodies to HLA Serum Reactivity.

Authors:  Baoshan Gao; Chunshu Rong; Fabrice Porcheray; Carolina Moore; Timothy C Girouard; Susan L Saidman; Waichi Wong; Yaowen Fu; Emmanuel Zorn
Journal:  Transplantation       Date:  2016-01       Impact factor: 4.939

7.  Cryptic B cell response to renal transplantation.

Authors:  R J Lynch; I A Silva; B J Chen; J D Punch; M Cascalho; J L Platt
Journal:  Am J Transplant       Date:  2013-06-10       Impact factor: 8.086

8.  Polyreactive antibodies plus complement enhance the phagocytosis of cells made apoptotic by UV-light or HIV.

Authors:  Zhao-hua Zhou; Teresa Wild; Ying Xiong; Laine H Sylvers; Yahong Zhang; Luxia Zhang; Larry Wahl; Sharon M Wahl; Steven Kozlowski; Abner L Notkins
Journal:  Sci Rep       Date:  2013       Impact factor: 4.996

9.  Stimulation of Toll-Like Receptors profoundly influences the titer of polyreactive antibodies in the circulation.

Authors:  Sreenivasulu Gunti; Ronald J Messer; Chengfu Xu; Ming Yan; William G Coleman; Karin E Peterson; Kim J Hasenkrug; Abner L Notkins
Journal:  Sci Rep       Date:  2015-10-14       Impact factor: 4.379

Review 10.  Autoantibodies targeting neuronal proteins as biomarkers for neurodegenerative diseases.

Authors:  Gabriela Kocurova; Jan Ricny; Saak V Ovsepian
Journal:  Theranostics       Date:  2022-03-28       Impact factor: 11.600

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.